Associated Papers
Structural Analysis of Missense Mutations on the Stability of APOE3 and APOE4.
Anthony M et al.
Genes, 2025
41465183 (PubMed )
Supplement: genes-16-01509-s001.zip › Supplementary_Table_S3_APOE3_2L7B_.xlsx › Sheet1
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
The Importance of Copy Number Variant Analysis in Patients with Monogenic Kidney Disease.
Claus LR et al.
Kidney International Reports, 2024
39291214 (PubMed )
Supplement: mmc1.xlsx › S2c._Multiple_occurences
Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN et al.
Diagnostic Pathology, 2021
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H et al.
Journal of Atherosclerosis and Thrombosis, 2018
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Matsunaga A et al.
Clinical and Experimental Nephrology, 2014
A case of lipoprotein glomerulopathy due to the pathogenic APOE Las Vegas variant c.509C > A: p. (Ala170Asp).
Mulder JWCM et al.
Journal of Clinical Lipidology, 0
Select a paper to view details